Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma
- Type
- Retraction
- Notice date
- 6/28/2023 0:00
- Journal
- Computational and Mathematical Methods in Medicine
- Publisher
- Hindawi
- Notice DOI
- 10.1155/2023/9823491
- Original paper DOI
- 10.1155/2022/4600145
Reasons
- Concerns/Issues about Data
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues about Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Unreliable Results and/or Conclusions